Kisqali Chemo - Search News

FDA Expands Approval Of Breast Cancer Drug Kisqali

FDA expands approval of breast cancer drug Kisqali to earlier-stage patients

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.

UPI News on MSN · 4d

FDA expands use of Kisqali to early stage breast cancer patients

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Yahoo · 4d

FDA expands use of Kisqali to early stage breast cancer patients

Kisqali reduced the risk of a breast cancer coming back by 25% after three years when given along with standard treatments, which can include chemotherapy, surgery and radiation followed by ...

Scripps News on MSN · 3d

Breast cancer drug Kisqali gets FDA approval to prevent cancer recurrence

The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce the chances of a patient's breast cancer coming back by 25%.

KTSM El Paso on MSN · 4d

FDA expanded their approval on drug cancer drug

First News

Yahoo · 4d

FDA expands approval of breast cancer drug Kisqali to earlier-stage patients

Kisqali reduced the risk of a patient’s breast cancer coming back by 25% after three years when given in addition to standard treatments, which can include chemotherapy, surgery and radiation ...

Targeted Oncology4d

Dual HER2 Blockade Plus Ribociclib Offers Chemo-Free Option in HR+/HER2+ Breast Cancer

Combining endocrine therapy with the dual HER2 blockade of trastuzumab and pertuzumab and the CDK4/6 inhibitor ribociclib ...

Zacks.com on MSN2d

Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

Medical Xpress4d

FDA expands use of breast cancer drug Kisqali

NBC New York5d

FDA expands approval of breast cancer drug Kisqali to earlier stage patients

(Nikki Odum) After she had a double mastectomy, chemotherapy and radiation, her doctor, Denise Yardley, asked if she wanted to join the clinical trial for Kisqali. “It was a no-brainer for me.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results